The Breast Cancer Channel

Explore the latest updates, including expert interviews and features

The Breast Cancer Channel on VJOncology is supported by Gilead and Seagen. These supporters have no influence over the production of the content.

Latest Videos Breast Cancer Sessions Topics SABCS 2021 Conferences Features Editorial Board

Welcome to the Breast Cancer Channel!

VJOncology brings you the latest updates in the field of breast cancer, keeping you up-to-date with the most exciting developments with video interviews, podcasts, and roundtable discussions, and more.

Reporting from key international congresses alongside our expert Editorial Board, catch up on the key advances in breast cancer, including the use of novel treatment approaches, key trial updates as well as the emerging role of treatment de-escalation.

Breast Cancer Videos by Topic

Immuno-Oncology
Surgery
Trial Updates
Molecular Profiling
Screening
1:04
Are combination approaches the way forward for treating patients with triple-negative breast cancer?
Sangeetha M. Reddy • 12 Apr 2022
2:09
Triplet combination of chemotherapy, CD40 agonist, and Flt3 ligand in triple-negative breast cancer
Sangeetha M. Reddy • 12 Apr 2022
1:24
Combining chemotherapy, CD40 agonist, and Flt3 ligand in triple-negative breast cancer
Sangeetha M. Reddy • 12 Apr 2022
1:04
Future directions in triple-negative breast cancer research
Sangeetha M. Reddy • 12 Apr 2022
View All Videos
1:18
eRAPID: electronic self-reporting of adverse events for patients undergoing cancer treatment
Galina Velikova • 3 May 2022
2:32
Survival benefit of a combined surgical approach in patients with metastatic breast cancer
Nadeem Bilani • 8 Dec 2021
6:47
TARGIT-IORT for early breast cancer
Jayant Vaidya • 5 Nov 2021
4:38
Non-radioactive magnetic seed-based breast tumor localization device under investigation in the UK
Edward St John • 13 Apr 2021
View All Videos
2:22
TRESR trial: Investigating an ATRi in patients with DNA damage repair loss-of-function mutant tumors
Timothy Yap • 13 Apr 2022
4:28
Update on PETRA trial investigating a next-generation PARP1 select inhibitor
Timothy Yap • 13 Apr 2022
0:59
Treatments for HR+ postmenopausal breast cancer
Meenakshi Anurag • 10 Apr 2022
0:31
Exciting developments in ADCs for BC presented at ESMO Breast 2022
Rupert Bartsch • 5 May 2022
View All Videos
6:29
Should polygenic risk scores be used to risk-stratify the use of PSA-screening in prostate cancer?
Andrew Vickers • 11 May 2022
1:29
LIG1 deletion predicts chemotherapy resistance in triple-negative breast cancer
Meenakshi Anurag • 10 Apr 2022
1:14
The importance of a biomarker-directed approach in triple-negative breast cancer
Meenakshi Anurag • 10 Apr 2022
1:21
The use of the Ki-67 in deciding which patients with HR+ breast cancer can safely avoid chemotherapy
Sung-Bae Kim • 4 May 2022
View All Videos
6:29
Should polygenic risk scores be used to risk-stratify the use of PSA-screening in prostate cancer?
Andrew Vickers • 11 May 2022
1:39
Using single cell technologies to identify biomarkers for breast cancer patient outcomes
Sofia Mastoraki • 11 Apr 2022
0:34
Unanswered questions in DCIS progression
Tanjina Kader • 11 Apr 2022
0:38
Clinical implications for recurrent nonclonal primary DCIS
Tanjina Kader • 11 Apr 2022
View All Videos

Breast Cancer Videos by Conference

ESMO Breast 2022
SABCS 2021
ESMO 2021
ASCO 2021
ESMO Breast 2021
AACR 2021
0:31
Exciting developments in ADCs for BC presented at ESMO Breast 2022
Rupert Bartsch • 5 May 2022
1:23
Exploring myeloid cells to reverse the hormone-mediated microenvironemnt of luminal breast cancer
Céline Blaye • 4 May 2022
0:27
Immunotherapy insights from ESMO Breast 2022
Céline Blaye • 4 May 2022
1:27
PRADA: evaluating radiotherapy before deep inferior flap reconstruction
Philip Poortmans • 3 May 2022
View All Videos
3:44
Correlation of Trop-2 expression with clinicopathological characteristics and outcome in TNBC
Hava Izci • 10 Dec 2021
3:50
The role of SOFT and TEXT in treatment decision making for patients with breast cancer
Meredith M. Regan • 12 Dec 2021
2:01
ASCENT: sacituzumab govitecan outperforms chemo in Black patients with TNBC
Lisa A. Carey • 7 Dec 2021
6:54
Key clinical trials investigating immunotherapy in HER2+ and HR+ breast cancer
Giuseppe Curigliano • 9 Dec 2021
View All Videos
2:06
NGS multi-panel gene testing for newly diagnosed patients with metastatic breast cancer
Evandro de Azambuja • 18 Sep 2021
4:40
AMEERA-1 updates: amcenestrant plus palbociclib for patients with ER+/HER2– advanced breast cancer
Mario Campone • 30 Sep 2021
2:46
Prognostic impact of immune interactions in patients with HER2+ and TNBC with brain metastases
Gaia Griguolo • 21 Sep 2021
2:38
HER2+ and TNBC highlights from ESMO 2021
Gaia Griguolo • 21 Sep 2021
View All Videos
1:30
Results of the Phase II GeparNuevo trial
Evandro de Azambuja • 11 Jun 2021
3:01
Top news in breast cancer from ASCO 2021
Nadia Harbeck • 7 Jun 2021
2:58
OlympiA: adjuvant olaparib following chemo significantly improves IDFS
Evandro de Azambuja • 11 Jun 2021
4:03
Phase I/II trial of zenocutuzumab for tumors with NRG1 fusions
Alison M. Schram • 4 Jun 2021
View All Videos
3:22
PTEN protein and gene expression as a biomarker in breast cancer
Nicola Fusco • 13 May 2021
3:15
Brain metastases in HER2+ breast cancer
Volkar Mueller • 12 May 2021
4:46
TLR4 & pSTAT3 expression on CTCs in metastatic breast cancer
Maria Papadaki • 14 May 2021
1:20
CTCs, EMT & immunosuppresive cells in metastatic breast cancer
Maria Papadaki • 14 May 2021
View All Videos
6:40
Overcoming resistance to PARPi in BRCA1-deficient breast cancer with STING agonists
Qiwei Wang • 23 Apr 2021
5:47
Prognostication using germline risk variants and RNA expression for breast cancer
Sheila Rajagopal • 9 Apr 2021
1:13
Endocrine therapy resistance in ER+ metastatic breast cancer
Nikhil Wagle • 19 Apr 2021
1:27
Treating ER+ breast cancer patients with endocrine therapy resistance
Nikhil Wagle • 19 Apr 2021
View All Videos

The Breast Cancer Channel on VJOncology is supported by Gilead and Seagen.

These supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Breast Cancer Channel, please contact us.
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals